The impacts of COVID‐19 measures on drug markets and drug use among a cohort of people who use methamphetamine in Victoria, Australia
Addiction · 2023
DOI: 10.1111/add.16189 ↗Kurz gefasst
Fachartikel in der Zeitschrift Addiction, 2023. Verfasst von Kasun Rathnayake und 12 weiteren Autor:innen. Beteiligte Einrichtung: Burnet Institute, Melbourne, Victoria, Australia. Hauptthemen laut MEDLINE: Methamphetamine, Amphetamine-Related Disorders, COVID-19, Illicit Drugs. Die Arbeit wurde bisher 11-mal zitiert (Crossref) und nennt 24 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: National Health and Medical Research Council.
Abstract (Originalsprache)
Background and Aims Few studies of the impacts of the coronavirus disease 2019 (COVID‐19) public health measures on drug markets and drug use patterns have used longitudinal data. We aimed to examine whether COVID‐19 measures were associated with increases in methamphetamine price, decreases in methamphetamine use frequency and subsequent changes in secondary outcomes of other drug use frequency in metropolitan Melbourne and regional Victoria.
Design
Longitudinal analysis framework was used from a longitudinal cohort of people who use methamphetamine.
Setting
Victoria state, Australia.
Participants
One hundred eighty‐five VMAX study participants who reported a methamphetamine purchase after the onset of the pandemic were used for the price paid analysis. Methamphetamine or other drug use frequency analysis was performed using 277 participants who used methamphetamine during the pandemic or in the year before the pandemic.
Measurements
Price paid per gram of methamphetamine derived from the most recent purchase price and most recent purchase quantity. Frequency of methamphetamine and other drug use measured as the average number of days per week used in the last month.
Findings
Compared with pre‐COVID‐19 period, methamphetamine prices increased by AUD351.63 ( P value
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Burnet Institute, Melbourne, Victoria, Australia.
- Faculty of Health, Deakin University, Melbourne, Victoria, Australia.
- School of Public Health and Preventive Medicine, Monash University, Melbourne, Victoria, Australia.
- Melbourne School of Population and Global Health, University of Melbourne, Melbourne, Victoria, Australia.
- School of Rural Health, Monash University, Bendigo, Victoria, Australia.
- Population Health Sciences, Bristol Medical School, University of Bristol, Bristol, UK.
ORCID-Profile: Kasun Rathnayake, Paul A Agius, Bernadette Ward, Matthew Hickman, Lisa Maher, Mark Stoové, Joseph S Doyle, Margaret Hellard, Anna Wilkinson, Brendan Quinn, Keith Sutton, Paul Dietze
Förderung
- National Health and Medical Research Council
Zitieren
APA
Rathnayake, K., Agius, P. A., Ward, B., Hickman, M., Maher, L., Stoové, M., Doyle, J. S., Hellard, M., Wilkinson, A., Quinn, B., Crawford, S., Sutton, K., & Dietze, P. (2023). The impacts of COVID‐19 measures on drug markets and drug use among a cohort of people who use methamphetamine in Victoria, Australia. Addiction. https://doi.org/10.1111/add.16189
Vancouver
Rathnayake K, Agius PA, Ward B, Hickman M, Maher L, Stoové M, et al. The impacts of COVID‐19 measures on drug markets and drug use among a cohort of people who use methamphetamine in Victoria, Australia. Addiction. 2023. doi:10.1111/add.16189
BibTeX
@article{Rathnayake2023,
author = {Rathnayake, Kasun and Agius, Paul A and Ward, Bernadette and Hickman, Matthew and Maher, Lisa and Stoové, Mark and Doyle, Joseph S and Hellard, Margaret and Wilkinson, Anna and Quinn, Brendan and Crawford, Sione and Sutton, Keith and Dietze, Paul},
title = {The impacts of COVID‐19 measures on drug markets and drug use among a cohort of people who use methamphetamine in Victoria, Australia},
journal = {Addiction},
year = {2023},
doi = {10.1111/add.16189}
}
EUVIMED